The adoption of biosimilars in correctional health care offers significant cost-saving potential but also presents clinical challenges. This presentation will discuss the development, approval process, and implementation of biosimilars. Topics include nomenclature, interchangeability, cost benefits, and practical recommendations tailored to correctional settings.

• Describe the development and regulatory approval process for biosimilars
• Discuss the unique challenges of implementing biosimilars in correctional settings and ways to overcome them
• Evaluate the cost-saving potential of biosimilars

Level: Intermediate